A lipid A analog inhibits LPS-induced cytokine expression and improves survival in endotoxemic mice

Immunopharmacology and Immunotoxicology

Volumn 18, Issue 4, 1996, Pages 477-495

  Someya, K ^a   Tsutomi, Y ^a   Soga, T ^a   Akahane, K ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DY 9973; INTERLEUKIN 1BETA; LIPID A DERIVATIVE; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MACROPHAGE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SEPTIC SHOCK;

ANIMALIA; MYCOBACTERIUM BOVIS BCG; NEGIBACTERIA;

EID: 0029828935     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.3109/08923979609052749     Document Type: Article

References (37)

1. Snell, R. J. and Parrillo, J. E., Cardiovascular dysfunction in septic shock, Chest., 99: 1000, 1991.
2. Loppnow, H., Libby, P., Freudenberg, M., Krauss, J. H., Weckesser, J. and Mayer, H., Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS, Infect. Immun., 58: 3743, 1990.
3. Dinarello, C. A., Interleukin-1 and interleukin-1 antagonism, Blood, 77: 1627, 1991.
4. Jirik, F. R., Podor, T. J., Hirano, T., Kishimoto, T., Loskutoff, D. J., Carson, D. A. and Lotz, M., Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells, J. Immunol., 142: 144, 1989.
5. Le, J., Lin, J. X., Henriksen-Destafano, D. and Vilcek, J., Bacterial lipopolysaccharide-induced interferon-γ production: role of interleukin 1 and interleukin 2, J. Immunol., 136: 4525, 1986.
6. Block, M. I., Berg, M., McNamara, M. J., Norton, J. A., Fraker, D. L. and Alexander, H. R., Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia, J. Exp. Med., 178: 1085, 1993.
7. Giroir, B. P., Johnson, J. H., Brown, T., Allen, G. L. and Beutler, B., The tissue distribution of tumor necrosis factor biosythesis during endotoxemia, J. Clin. Invest., 90: 693, 1992.
8. Van Deventer, S. J. H., Bueller, H. R., ten Cate, J. W., Aarden, L. A., Hack, C. E. and Sturk, A., Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic, and complement pathways, Blood, 76: 2520, 1990.
9. Suter, P. M., Suter, S., Girardin, E., Roux-Lombard, P., Grau, G. E. and Dayer, J.-M., High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis, Am. Rev. Respir. Dis., 145: 1016, 1992.
10. Warring, P., Wycherley, K., Cary, D., Nicola, N. and Metcalf, D., Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids, J. Clin, Invest., 90: 2031, 1992.
11. Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., Zentella, A., Albert, J. D., Shires, G. T. and Cerami, A., Shock and tissue injury induced by recombinant human cachectin, Sci., 234: 470, 1986.
12. Beutler, B., Milsark, I. W. and Cerami, A. C., Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxins, Sci., 229: 869, 1985.
13. Ziegler, E. J., Fisher, C. J., Jr., Sprung, C. L., Strube, R. C., Sadoff, J. C., Foulke, G. E., Wortel, C. H., Fink, M. P., Dellinger, R. P., Teng, N. N. H., Allen, I. E., Berger, H. J., Knatterud, G. L., Lobuglio, A. F., Smith, C. R. and the HA-1A Sepsis Study Group., Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin, N. Engl. J. Med., 324: 429, 1991.
14. Gallay, P., Heumann, D., Roy, D., Barras, C. and Glauser, M. P., Lipopolysaccharide-binding protein as a major plasma protein responsible for endotoxic shock, Proc. Natl. Acad. Sci. USA, 90: 9935, 1993.
15. Tracey, K. J., Fong, Y. and Hesse, D. G., Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia, Nature, 330: 662, 1987.
16. Bean, A. G. D., Freiberg, R. A., Andrade, S., Menon, S. and Zlotnik, A., Interleukin 10 protects mice against staphylococcal endotoxin B-induced lethal shock, Infect. Immun., 61: 4937, 1993.
17. Mohler, K. M., Torrance, D. S., Smith, C. A., Goodwin, R. G., Stremler, K. E., Fung, V. P., Madani, H. and Widmer, M. B., Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists, J. Immunol., 151: 1548, 1993.
18. Fischer, E., Marano, M. A., Van Zee, K. J., Rock, C. S., Hawes, A. S., Thompson, W. A., DeForge, L., Kenney, J. S., Remick, D. G., Bloedow, D. C., Thompson, R. C., Lowry, S. F. and Moldawer, L. L., Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fail to alter host responses to sublethal endotoxemia, J. Clin. Invest., 89: 1551, 1992.
19. Ogata, M., Matsumoto, T., Koga, K., Takenaka, I., Kamochi, M., Sata, T., Yoshida, S. and Shigematsu, A., An antagonist of platelet-activating factor suppresses endotoxin-induced tumor necrosis factor and mortality in mice pretreated with carrageenan, Infect. Immun., 61: 699, 1993.
20. Apte, R. N., Galanos, C. and Pluznik, D. H., Lipid A, the active part of bacterial endotoxin in inducing serum colony stimulating activity and proliferation of splenic granulocyte-macrophage progenitor cells, J. Cell. Physiol., 87: 71, 1976.
21. Reitschel, E. T., Brade, H., Brade, L., Brandenburg, K., Schade, U. F., Seydel, U., Zahringer, U., Galanos, C., Luderitz, O., Westphal, O., Labischinski, H., Kusumoto, S. and Shiba, T., Lipid A, the endotoxic center of bacterial lipopolysaccharide: relation of chemical structure to biological activity, Prog. Clin. Biol. Res., 231: 25, 1987.
22. Kiener, P. A., Marek, F., Rodgers, G., Lin, P. F., Warr, G. and Desiderio, J., Induction of tumor necrosis factor, IFN-gamma, and acute lethality in mice by toxic and non-toxic forms of lipid A, J. Immunol., 141: 870, 1988.
23. Golenbock, D. T., Hampton, R. Y., Qureshi, N., Takayama, K. and Raetz, C. R. H., Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes, J. Biol. Chem., 266: 19490, 1991.
24. Lynn, W. A., Raetz, C. R. H., Qureshi, N. and Golenbock, D. T., Lipopolysaccharide-induced stimulation of CD11b/CD18 expression on neutrophils, J. Immunol., 147: 3072, 1991.
25. A inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo, J. Exp. Med., 172: 77, 1990.
26. Lei, M. G., Stimpsopn, S. A. and Morrison, D. C., Specific endotoxic lipopolysaccharide-binding receptors on murine splenocytes, J. Immunol., 147: 1925, 1991.
27. William, A. and Golenbock, D. T., Lipopolysaccharide antagonists, Immunol. Today, 13: 271, 1992.
28. Akahane, K., Someya, K., Tsutomi, Y., Akimoto, T. and Tohgo, A., Antitumor synthetic lipid A analog DT-5461a upregulates cytokine expression in a murine macrophage cell line through LPS pathway, Cell. Immunol., 155: 42, 1994.
29. Chomczynski, P. and Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem., 162: 156, 1987.
30. Akahane, K., Cohen, R. B., Bickel, M. and Pluznik, D. H., IL-1α induces granulocyte-macrophage colony-stimulating factor gene expression in murine B lymphocyte cell lines via mRNA stabilization, J. Immunol., 146: 4190, 1991.
31. Akahane, K. and Pluznik, D. H., Interleukin-4 inhibits interleukin-1α induced granulocyte-macrophage colony-stimulating factor gene expression in a murine B lymphocyte cell line via down regulation of RNA precursor, Blood, 79: 3188, 1992.
32. Akahane, K. and Pluzunik, D. H., Interferon-γ destabilizes interleukin-1-induced granulocyte-macrophage colony-stimulating factor mRNA in murine vascular endothelial cells, Exp. Hematol., 21: 878, 1993.
33. Lee, J. D., Kato, K., Tobias, P. S., Kirkland, T. N. and Ulevitch, R. J., Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein, J. Exp. Med., 175: 1697, 1992.
34. Ferrero, E., Jiao, D., Tsuberi, B. Z., Tesio, L., Rong, G. W., Haziot, A. and Goyert, S. M., Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide, Proc Natl Acad Sci USA, 90: 2380, 1993.
35. Munford, R. S., Hall, C. L., Lipton, J. M. and Dietschy, J. M., Biological activity, lipoprotein-binding behavior, and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides, J. Clin. Invest., 70: 877, 1982.
36. Kelly, C. J., Cech, A. C., Argenteanu, M., Gallagher, H., Shou, J., Minnard, E. and Daly, J. M., Role of bacterial permeability-increasing protein in the treatment of gram-negative pneumonia, Surgery, 114: 140, 1993.
37. Christ, W. J., Asano, O., Robidoux, A. L. C., Perez, M., Wang, Y., Dubuc, G. R. G., W.E., Hawkins, L. D., McGuinness, P. D., Mullarkey, M. A., Lewis, M. D., Kishi, Y., Kawata, T., Bristrol, J. R., Rose, J. R., Rossignol, D. P., Koboyashi, S., Hishinuma, I., Kimura, A., Asakawa, N., Katayama, K. and Yamatu, I., E5531, a pure endotoxin antagonist of high potency, Sci., 268: 80, 1995.